Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tanvi Dhere

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Msphere|October 15, 2020
Gram-Negative Taxa and Antimicrobial Susceptibility after Fecal Microbiota Transplantation for Recurrent Clostridioides difficile InfectionDanielle Barrios Steed, Tiffany Wang, Divyanshu Raheja, et al.
Inflammatory Bowel Diseases|November 18, 2021
Corrigendum to: Intracolonic Neuropeptide Y Y1 Receptor Inhibition Attenuates Intestinal Inflammation in Murine Colitis and Cytokine Release in IBD BiopsiesBindu Chandrasekharan, Darra Boyer, Joshua A Owens, et al.
Inflammatory Bowel Diseases|October 6, 2021
Intracolonic Neuropeptide Y Y1 Receptor Inhibition Attenuates Intestinal Inflammation in Murine Colitis and Cytokine Release in IBD BiopsiesBindu Chandrasekharan, Darra Boyer, Joshua A Owens, et al.
Therapeutic Advances in Gastroenterology|May 3, 2016
Fecal microbiota transplant for Clostridium difficile infection in older adultsWilliam M Tauxe, John P Haydek, Paulina A Rebolledo, et al.
Journal of Clinical Microbiology|January 13, 2017
Laboratory Testing of Donors and Stool Samples for Fecal Microbiota Transplantation for Recurrent Clostridium difficile InfectionMichael H Woodworth, Emma M Neish, Nancy S Miller, et al.
Journal of Clinical Microbiology|June 16, 2021
Fecal Microbiota Transplantation Donor Screening Updates and Research Gaps for Solid Organ Transplant RecipientsNirja Mehta, Tiffany Wang, Rachel J Friedman-Moraco, et al.
Inflammatory Bowel Diseases|March 27, 2012
Common NOD2 risk variants in African Americans with Crohn's disease are due exclusively to recent Caucasian admixtureOloruntosin Adeyanju, David T Okou, Clifton Huang, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 16, 2018
Tacrolimus concentration to dose ratio in solid organ transplant patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infectionMichael H Woodworth, Colleen S Kraft, Erika J Meredith, et al.
Inflammatory Bowel Diseases|December 17, 2009
Genome wide association (GWA) predictors of anti-TNFalpha therapeutic responsiveness in pediatric inflammatory bowel diseaseMarla C Dubinsky, Ling Mei, Madison Friedman, et al.
The Journal of Infectious Diseases|February 25, 2016
A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile InfectionSahil Khanna, Darrell S Pardi, Colleen R Kelly, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Msphere|October 15, 2020
Gram-Negative Taxa and Antimicrobial Susceptibility after Fecal Microbiota Transplantation for Recurrent Clostridioides difficile InfectionDanielle Barrios Steed, Tiffany Wang, Divyanshu Raheja, et al.
Inflammatory Bowel Diseases|November 18, 2021
Corrigendum to: Intracolonic Neuropeptide Y Y1 Receptor Inhibition Attenuates Intestinal Inflammation in Murine Colitis and Cytokine Release in IBD BiopsiesBindu Chandrasekharan, Darra Boyer, Joshua A Owens, et al.
Inflammatory Bowel Diseases|October 6, 2021
Intracolonic Neuropeptide Y Y1 Receptor Inhibition Attenuates Intestinal Inflammation in Murine Colitis and Cytokine Release in IBD BiopsiesBindu Chandrasekharan, Darra Boyer, Joshua A Owens, et al.
Therapeutic Advances in Gastroenterology|May 3, 2016
Fecal microbiota transplant for Clostridium difficile infection in older adultsWilliam M Tauxe, John P Haydek, Paulina A Rebolledo, et al.
Journal of Clinical Microbiology|January 13, 2017
Laboratory Testing of Donors and Stool Samples for Fecal Microbiota Transplantation for Recurrent Clostridium difficile InfectionMichael H Woodworth, Emma M Neish, Nancy S Miller, et al.
Journal of Clinical Microbiology|June 16, 2021
Fecal Microbiota Transplantation Donor Screening Updates and Research Gaps for Solid Organ Transplant RecipientsNirja Mehta, Tiffany Wang, Rachel J Friedman-Moraco, et al.
Inflammatory Bowel Diseases|March 27, 2012
Common NOD2 risk variants in African Americans with Crohn's disease are due exclusively to recent Caucasian admixtureOloruntosin Adeyanju, David T Okou, Clifton Huang, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 16, 2018
Tacrolimus concentration to dose ratio in solid organ transplant patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infectionMichael H Woodworth, Colleen S Kraft, Erika J Meredith, et al.
Inflammatory Bowel Diseases|December 17, 2009
Genome wide association (GWA) predictors of anti-TNFalpha therapeutic responsiveness in pediatric inflammatory bowel diseaseMarla C Dubinsky, Ling Mei, Madison Friedman, et al.
The Journal of Infectious Diseases|February 25, 2016
A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile InfectionSahil Khanna, Darrell S Pardi, Colleen R Kelly, et al.
Pageof 4